CA2110410C - Therapeutic compositions for osteoinduction - Google Patents

Therapeutic compositions for osteoinduction

Info

Publication number
CA2110410C
CA2110410C CA002110410A CA2110410A CA2110410C CA 2110410 C CA2110410 C CA 2110410C CA 002110410 A CA002110410 A CA 002110410A CA 2110410 A CA2110410 A CA 2110410A CA 2110410 C CA2110410 C CA 2110410C
Authority
CA
Canada
Prior art keywords
bmp
vitamin
issued
bone
deluca
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002110410A
Other languages
English (en)
French (fr)
Other versions
CA2110410A1 (en
Inventor
Roger Lee Stone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of CA2110410A1 publication Critical patent/CA2110410A1/en
Application granted granted Critical
Publication of CA2110410C publication Critical patent/CA2110410C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002110410A 1991-06-05 1992-05-26 Therapeutic compositions for osteoinduction Expired - Fee Related CA2110410C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US70962191A 1991-06-05 1991-06-05
US709,621 1991-06-05
US85611092A 1992-03-27 1992-03-27
US856,110 1992-03-27

Publications (2)

Publication Number Publication Date
CA2110410A1 CA2110410A1 (en) 1992-12-10
CA2110410C true CA2110410C (en) 1997-04-15

Family

ID=27108286

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002110410A Expired - Fee Related CA2110410C (en) 1991-06-05 1992-05-26 Therapeutic compositions for osteoinduction

Country Status (13)

Country Link
EP (1) EP0587751A1 (no)
JP (1) JPH06508140A (no)
AU (1) AU667815B2 (no)
BR (1) BR9206110A (no)
CA (1) CA2110410C (no)
CZ (1) CZ282231B6 (no)
IE (1) IE921812A1 (no)
NO (1) NO934381L (no)
NZ (1) NZ243018A (no)
PT (1) PT100567A (no)
RU (1) RU2107512C1 (no)
SK (1) SK136693A3 (no)
WO (1) WO1992021365A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
EP0601135B1 (en) * 1991-08-30 2005-11-02 Curis, Inc. Osteogenic proteins in the treatment of metabolic bone diseases
US6071695A (en) * 1992-02-21 2000-06-06 Creative Biomolecules, Inc. Methods and products for identification of modulators of osteogenic protein-1 gene expression
CN1104257C (zh) * 1993-03-29 2003-04-02 津莫吉尼蒂克斯公司 含pdgf和维生素d的刺激成骨细胞生长的组合物
CA2191583C (en) * 1994-06-07 2007-03-27 Engin Ozkaynak Methods and compositions for modulating morphogenic protein expression
US7026292B1 (en) 1995-12-12 2006-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6492508B1 (en) 1996-06-03 2002-12-10 United States Surgical Corp. A Division Of Tyco Healthcare Group Nucleic acids encoding extracellular matrix proteins
EP2332564A1 (en) * 1997-02-07 2011-06-15 Stryker Corporation Matrix-free osteogenic devices, implants and methods thereof
JP4255382B2 (ja) * 2001-10-31 2009-04-15 アルコン，インコーポレイテッド 骨形成タンパク質（ｂｍｐ）、ｂｍｐレセプターおよびｂｍｐ結合タンパク質ならびに緑内障の診断および処置におけるそれらの使用
CN104257667B (zh) * 2007-04-25 2019-06-04 欧普科Ip 控股Ii 有限公司 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的方法和组合物
US20100204123A1 (en) * 2009-02-12 2010-08-12 Mary Elizabeth Pecquet Goad Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease
CA2752160A1 (en) * 2009-02-12 2010-08-19 Stryker Corporation Compositions and methods for minimally-invasive systemic delivery of proteins including tgf-.beta. superfamily members
RU2595804C1 (ru) * 2015-04-23 2016-08-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Состав для получения стоматологической лечебно-профилактической пленки

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833125A (en) * 1986-12-05 1989-05-23 The General Hospital Corporation Method of increasing bone mass

Also Published As

Publication number Publication date
EP0587751A1 (en) 1994-03-23
WO1992021365A1 (en) 1992-12-10
PT100567A (pt) 1994-01-31
NZ243018A (en) 1995-12-21
AU2145492A (en) 1993-01-08
IE921812A1 (en) 1992-12-16
CZ262493A3 (en) 1994-07-13
BR9206110A (pt) 1995-07-11
SK136693A3 (en) 1994-10-05
CA2110410A1 (en) 1992-12-10
NO934381D0 (no) 1993-12-02
AU667815B2 (en) 1996-04-18
NO934381L (no) 1994-01-31
JPH06508140A (ja) 1994-09-14
RU2107512C1 (ru) 1998-03-27
CZ282231B6 (cs) 1997-06-11

Similar Documents

Publication Publication Date Title
US5693615A (en) Therapeutic compositions for osteoinduction
CA2110410C (en) Therapeutic compositions for osteoinduction
US5422340A (en) TGF-βformulation for inducing bone growth
EP0679097B1 (en) Tgf-beta formulation for inducing bone growth
Simion et al. Vertical ridge augmentation by means of deproteinized bovine bone block and recombinant human platelet-derived growth factor-BB: a histologic study in a dog model.
Herford et al. Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2)
AU2005328325B2 (en) Activating extraction of demineralized bone matrix
US9610320B2 (en) Surgical applications for BMP binding protein
US9089606B2 (en) Brain-derived neurotrophic factor or neurotrophin-4/5 to treat periodontal diseases and pulpal diseases
CA2417207C (en) Dental products comprising bone growth enhancing peptide
US20220233751A1 (en) Bone putty for bone pore and void filling
TWI611805B (zh) 用於治療坐骨神經損傷之醫藥組合物
Al Hawsawi et al. Anonychia congenita totalis: a case report and review of the literature
Richardson et al. Case 38-2004: A 40-year-old man with a large tumor of the skull
KR950703993A (ko) 치주 조직 질환 치료제(periodonal disease remedy)
Jackson Assessment of the closure of critical sized defects in the rabbit calvarium utilizing demineralized bone matrix putty as an allogenic graft material
Kirn Orthopedic surgeons ponder: how best to secure artificial hip prostheses?
ANDREWS THE EFFECTS OF CALCITONIN DURING RAPID PALATAL EXPANSION IN DOGS
McCoy A hypothetical explanation for the aging of skin: Imayama S, Braverman IM. Am J Pathol 134: 1019, 1989
FR2781376A1 (fr) Composition protectrice et regulatrice de l'homeostasie de la masse osseuse contenant des polymeres ou biopolymeres et leurs utilisations

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed